METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13
- 1 February 2005
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 33 (2) , 258-261
- https://doi.org/10.1124/dmd.104.002105
Abstract
Nicotine, a major constituent of tobacco, plays a critical role in smoking addiction. In humans, nicotine is primarily metabolized to cotinine, which is further metabolized to trans-3′-hydroxycotinine. Recently, we have demonstrated that heterologously expressed human CYP2A13 is highly active in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a nicotine-derived carcinogen. In the present study, CYP2A13-catalyzed NNK metabolism was found to be inhibited competitively by nicotine and N′-nitrosonornicotine (NNN), suggesting that both nicotine and NNN are also substrates of CYP2A13. We have further demonstrated that human CYP2A13 is indeed an efficient enzyme in catalyzing C-oxidation of nicotine to form cotinine, with the apparent Km and Vmax values of 20.2 μM and 8.7 pmol/min/pmol, respectively. CYP2A13 also catalyzes the 3′-hydroxylation of cotinine to form trans-3′-hydroxycotinine, with the apparent Km and Vmax values of 45.2 μM and 0.7 pmol/min/pmol, respectively. The importance of CYP2A13-catalyzed nicotine and cotinine metabolism in vivo remains to be determined.Keywords
This publication has 19 references indexed in Scilit:
- The Significance of the Homozygous CYP2A6 Deletion on Nicotine Metabolism: A New Genotyping Method of CYP2A6 Using a Single PCR–RFLPBiochemical and Biophysical Research Communications, 1999
- Characterization of Multiple Products of Cytochrome P450 2A6-Catalyzed Cotinine MetabolismChemical Research in Toxicology, 1999
- Expression of CYP2A genes in human liver and extrahepatic tissuesBiochemical Pharmacology, 1999
- Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cellsCarcinogenesis: Integrative Cancer Research, 1998
- The CYP2 A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesisPharmacogenetics, 1995
- Individual Expression of Carcinogen-Metabolizing Enzymes: Cytochrome P4502AJournal of Occupational and Environmental Medicine, 1995
- Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lungCarcinogenesis: Integrative Cancer Research, 1992
- Synthesis of (3'R,5'S)-trans-3'-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3'-hydroxycotinine in humans is highly stereoselectiveJournal of Medicinal Chemistry, 1990
- Recent studies of nicotine metabolism in humansPharmacology Biochemistry and Behavior, 1988
- The metabolism of nicotine-Δ1′(5′)-iminium ion,in vivo andin vitroEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982